Skip to content

Conduent Incorporated CNDT Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount

Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount at other companies

AbCellera Biologics Inc. logo
AbCellera Biologics Inc.ABCL
$1.5M-27.0%
CarGurus, Inc. logo
CarGurus, Inc.CARG
$980.25K
ESN
Essent GroupESNT
$79K-61.8%
Vertex, Inc. logo
Vertex, Inc.VERX
$1.13M-8.4%
Bicara Therapeutics logo
Bicara TherapeuticsBCAX
$844.25K
BioCryst Pharmaceuticals logo
BioCryst PharmaceuticalsBCRX
$330.75K-25.0%

Other financials

Income statement

See full
Revenue$723.0M-3.7%
Gross profit$136.0M+2.3%
Net income-$33.0M+35.3%
EPS (diluted)-$0.23+30.3%

Balance sheet

See full
Cash & equivalents$251.0M-14.3%
Total debt$952.0M+4.7%
Total equity$641.0M-19.9%
Total assets$2.4B-5.5%

Cash flow

See full
Operating cash flow-$8.0M+86.2%
CapEx$9.0M-35.7%
Free cash flow-$17.0M+76.4%

Valuation

See full
Market cap$226.44M-46.2%
Enterprise value$927.44M-11.1%
P/S0.1×-0.1×

Profitability

See full
Gross margin18.4%+0.4pp
Net margin-5%-14.1pp
FCF margin-0.7%-0.2pp

Returns & leverage

See full
Return on equity-21.1%-59.5pp
Debt / equity1.5×+0.3×
Current ratio1.6×-0.1×

Where this comes from

Reported directly by Conduent Incorporated in its filing.

Tagged under the XBRL concept us-gaap:IncomeTaxReconciliationTaxCreditsResearch.

The official record: Conduent Incorporated’s 10-K, filed February 19, 2026, on SEC EDGAR. View the filing →

Ask your AI about Conduent Incorporated's effective income tax rate reconciliation, tax credit, research, amount.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Conduent Incorporated's effective income tax rate reconciliation, tax credit, research, amount?
Conduent Incorporated (CNDT) reported effective income tax rate reconciliation, tax credit, research, amount of $1.5M in Q4 2025.
What does effective income tax rate reconciliation, tax credit, research, amount mean?
The total dollar value of research and development tax credits applied to reduce the company's income tax liability. This reflects the tax savings generated by the company's investment in innovation and product development activities.